Study

View clinical trials related to the Laboratory of Molecular Hematopoiesis

A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), eltrombopag, in Moderate Aplastic Anemia Patients

11-H-0134 A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), eltrombopag, in Moderate Aplastic Anemia Patients

To evaluate the safety and effectiveness of eltrombopag in people with moderate aplastic anemia or patients with bone marrow failure and unilineage cytopeniawho need treatment for significantly low blood cell counts.

For further information on clinical trial participation, go to the trial links on clintrials.gov or contact Evette Barranta RN, barrantae@nhlbi.nih.gov, 301-827-4421.

Extended Dosing with eltrombopag in Refractory Severe Aplastic Anemia

13-H-0133 Extended Dosing with eltrombopag in Refractory Severe Aplastic Anemia

To look at whether 6 months of treatment with eltrombopag can improve patient s blood counts.

For further information on clinical trial participation, go to the trial links on clintrials.gov or contact Evette Barranta RN, barrantae@nhlbi.nih.gov, 301-827-4421.